016–Treatment Adherence to Somavaratan (VRS-317), a Long-Acting Growth Hormone for Children with Growth Hormone Deficiency (GHD): the VISTA Trial
2017
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI